← Back to Search

exercise for Cystic Fibrosis

N/A
Waitlist Available
Led By Dave Burnett, Ph.D.
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This study is evaluating whether exercise can improve the health of individuals with cystic fibrosis.

Eligible Conditions
  • Cystic Fibrosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Aerobic Exercise Capacity
Secondary outcome measures
Impact on sweat chloride
Quality of Life measured by CFQ-R
diabetes risk
+1 more

Trial Design

2Treatment groups
Active Control
Group I: exerciseActive Control1 Intervention
exercise prescription + standard of care
Group II: no exerciseActive Control1 Intervention
no exercise prescription + standard of care

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
462 Previous Clinical Trials
169,198 Total Patients Enrolled
8 Trials studying Cystic Fibrosis
254 Patients Enrolled for Cystic Fibrosis
Dave Burnett, Ph.D.3.06 ReviewsPrincipal Investigator - University of Kansas Medical Center
University of Kansas Medical Center
5Patient Review
I appreciate that I didn't have to wait long to be seen. The physician was very attentive and took the time to answer all of my questions. I always feel like I'm in charge of my healthcare when I'm here — which is exactly how it should be.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025